drugset / Trial / NCT05147844
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Phase 2
Recruiting
40 enrolled
Xinqiao Hospital of Chongqing
Chongqing University Cancer Hospital · collabDaping Hospital and the Research Institute of Surgery of the Third Military Medical University · collabSouthwest Hospital, China · collab
NaSingle-groupOpen-labelTreatment
Summary
The aim of the study was to determine the efficacy and safety of toripalimab combined with radiotherapy in the treatment of oligometastatic nasopharyngeal carcinoma
Timeline
- Start
- 2022-03-01
- Primary completion
- 2025-12-31
- Completion
- 2026-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toripalimab | Monoclonal antibody | 240 mg | Intravenous |